GUIA DE SEGUIMIENTO FARMACOTERAPEUTICO SOBRE DIABETES PDF

que la mortalidad a largo plazo esté relacionada sobre todo con la recidiva de la enfermedad actuaciones en una guía de seguimiento del paciente trasplantado. . documento recoge recomendaciones farmacoterapéuticas, de autocuidado, de . de las guías. • Algunos pacientes pueden comenzar con una diabetes de. Efectividad del seguimiento farmacoterapéutico en diabéticos tipo 2 clínica, se obtuvo información sobre medicamentos antidiabéticos utilizados, dosis, .. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Objetivos: Realizar un seguimiento farmacoterapéutico y educar a pacientes conocimiento sobre la menopausia y la THR en pacientes menopaúsicas. Keywords: Hormone . ministerial que generará Guías Clínicas y tratará . stock de éste por el laboratorio que los produce. Diabetes. 38%. Depresión.

Author: Gomuro Kagalkree
Country: Mauritania
Language: English (Spanish)
Genre: Sex
Published (Last): 22 March 2017
Pages: 108
PDF File Size: 4.85 Mb
ePub File Size: 20.4 Mb
ISBN: 917-8-49053-748-9
Downloads: 99709
Price: Free* [*Free Regsitration Required]
Uploader: Moogulmaran

During each of the interviews of the patients in the intervention and control groups, we identified the NOM and the possible causes. The outcomes of the pharmaceutical interventions in the study were statistically analyzed with the STATA program version Barroso A, Moral G. Increased effectiveness of the antidiabetic therapy was not demonstrated in patients intervened with pharmacotherapeutical monitoring, but we did obtain a reduction in healthcare costs.

Rev Asoc Latinoam Diabetes. The highest prescription was for Group C, Cardiovascular System, with medications; this means that patients with CKD are administered a higher number of medications acting upon this physiological system.

There were no cases of Quantitative Insecurity. La HbA1c inicial tuvo un promedio de 7. Diabetes mellitus DM is an increasingly occurring disease, which generates important sbre that affect the quality of life of patients; hence, its care generates high costs, given that it farnacoterapeutico a disease of utmost interest for public health. The distribution of the different study and sociodemographic variables can be seen in Table 1. It was calculated that the among the main antidiabetic medications consumed [Defined Daily Dose DDD ] glibenclamide represented 0.

According to studies, Clinical Pharmacy has ensured an increase in the knowledge of medications by patients, a reduction in hospitalization rate, and an improvement in their quality of life 18 diabtes, There was no significant difference found in CKD patients regarding gender; that is to say, male patients are at the same risk of developing it as female patients.

Of these 6 non-accepted interventions, 3 health problems were not solved, 12 dose readjustments were conducted, with cefepime as the drug with the highest number of dose adjustments; most patients were in Diaabetes III and V of CKD, and its main cause was hypertension and Diabetes Mellitus II.

In nephropathy cases with hypoalbuminemia, drug effects of higher intensity can develop as a consequence of a reduced binding to plasma proteins and the subsequent increase in the free circulating fraction of the drug. Finally, it must be stated that the results are only applicable to populations of diabetic patients with similar characteristics who are affiliated to the contributive healthcare regime of Colombia’s General System of Health and Social Security.

  LOVER BEWARE CHRISTINE FEEHAN PDF

That is why Pharmaceutical Care should include SOPs structured by ee reached by consensus to conduct Pharmaceutical Care Practice, which will enable to prevent, identify and solve any negative outcomes in patients that are associated with medication. During the study, the patients were visited on at least three instances, establishing the NOMs in each visit.

The economic analysis between conducting interventions or keeping patients under habitual control, suggests to healthcare insurance carriers that implementing pharmacotherapeutic monitoring programs in patients with type-2 diabetes, may generate savings in costs related to caring for these patients. An intervention study was carried out during 19 months, between May and Januarydiabeets evaluate the effectiveness of pharmacotherapeutic monitoring to reduce HbA1c in patients with type 2 diabetes mellitus.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica [WorldCat Identities]

Besides, in our study, there were more reports for Quantitative Ineffectiveness; the reason for this was the lack of modification in treatment dosing, even when this was allowed by the therapeutic window of drugs. Glycemic control and type 2 diabetes mellitus: In Barranquilla, the prevalence of CKD is of approximately 46 persons perinhabitants 1.

Quality of diabetes care in US academic medical centers: A descriptive analysis was performed of the cost variable for each of the EPSs and in each of the groups.

Stemer G, Lemmens G. Rev Panam Salud Publica. Initial HbA1c mean was 7. Causes of NOM identified in the study patients can be seen in Table 3.

HbA1c findings and antidiabetic medication consumption. It must be stated that the pharmacotherapeutic monitoring was carried out by the drug dispensing entity and not by the healthcare provider, for this reason the cost was not charged to the direct costs of patient healthcare.

There is also evidence in that the results of pharmaceutical care may lead to reduced utilization of healthcare services and to a lower number of medications prescribed NOMs can be classified into three types: There no important variations or statistically significant differences in HbA1c values for patients in the intervention and control groups at the end of the study; although there rarmacoterapeutico a reduction in values of glycated hemoglobin in the intervention group, making it convenient to suggest a similar study with a bigger population sample and a better control of losses.

Seguimiento farmacoterapéutico en pacientes con insuficiencia renal crónica

Quality and effectiveness of diabetes care for seyuimiento group of patients in Colombia. The NOMs with the highest prevalence were those for Non-Quantitative Insecurity; therefore, these represent a highly prevalent problem. Like a snake in the grass. A population-based survey in an urban community. The study initially had patients, in the intervention group and in the control group, but during the course of the study 80 patients were lost from the sample because of different causes, ending the study with patients All this based on good communication and cooperation between the patient and health personnel 9.

  KEPMENDIKNAS 045 U 2002 PDF

Achievement of American Diabetes Association clinical practice recommendations among US adults with diabetes, Using the random number table method, we assigned the groups in random and stratified manner; in the intervention group, who had pharmacotherapeutic farmacpterapeutico for 18 months; and in the control group, who were merely interviewed at the beginning and at the end of the study. The inability by patients to excrete drugs that are eliminated through the kidneys can lead to a build-up or metabolites, in case of repeated administration.

Diabetes trends in Latin America. Necessity NOMs showed that not all the health problems are being treated in these patients; that is to say, only their basal disease was controlled, while the problems caused by it were being overlooked. Patients in the control group were subjected to HbA1c measurement at the beginning and end of the study; they also had an initial interview with the pharmacotherapeutical record format, according to the DADER methodology.

Only 39 patients Inf Ter Nac Salud. Because the statistics for hypothesis tests were not significant, we opted for a bivariate analysis for the quantitative parameters via hazard ratios. A total of 41 pharmaceutical interventions were conducted, 35 were accepted and 6 were not accepted.

In the future, in case pharmacotherapeutic monitoring is incorporated to daily care of diabetic patients, commitment is needed from healthcare insurance carriers EPS to make available the offices for the interviews, facilitate easier access to clinical records and paraclinical exams, updates of member addresses, generation of settings for meetings and discussion with treating physicians to socialize the NOM findings and the pharmaceutical recommendations, implement recommendations, and evaluate results.

Effectiveness NOMS were those with the highest proportion.

Universidad de Granada Grupo de Investigación en Atención Farmacéutica

In order to ensure patient safety as a component of quality of care 7Pharmaceutical Care Practice PCP must be conducted as a clinical activity within Pharmaceutical Care PCwith the objective of reducing the morbimortality associated with the use of medications, through activities performed by the Pharmacist, who will be responsible for identifying the needs of the patient regarding pharmacological treatment, with the aim to achieve results that will improve the quality of life of patients, working together with the healthcare team in order to make decisions about the treatment initiated, to ensure its safety and efficacy 8.

To determine the effectiveness of pharmaceutical sbre to improve control of type-2 diabetes mellitus. The impact of chronic kidney disease in health is no longer just a patient-physician issue, not only in terms of the increase in the number of patients diagnosed, but also idabetes the human and economic cost for health faarmacoterapeutico.